These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28560951)

  • 21. microRNA-130a Promotes Human Keratinocyte Viability and Migration and Inhibits Apoptosis Through Direct Regulation of STK40-Mediated NF-κB Pathway and Indirect Regulation of SOX9-Meditated JNK/MAPK Pathway: A Potential Role in Psoriasis.
    Xiong Y; Chen H; Liu L; Lu L; Wang Z; Tian F; Zhao Y
    DNA Cell Biol; 2017 Mar; 36(3):219-226. PubMed ID: 28085489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-205-3p promotes proliferation and reduces apoptosis of breast cancer MCF-7 cells and is associated with poor prognosis of breast cancer patients.
    Qiu C; Huang F; Zhang Q; Chen W; Zhang H
    J Clin Lab Anal; 2019 Oct; 33(8):e22966. PubMed ID: 31578772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circNINL promotes breast cancer progression through activating β-catenin signaling via miR-921/ADAM9 axis.
    Xu C; Yu H; Yin X; Zhang J; Liu C; Qi H; Liu P
    J Biochem; 2021 Sep; 169(6):693-700. PubMed ID: 33479730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-21 regulates the ACAT1 gene in MCF-7 cells.
    Chanyshev MD; Razumova YV; Ovchinnikov VY; Gulyaeva LF
    Life Sci; 2018 Sep; 209():173-178. PubMed ID: 30092298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H; Pan H; Qian Y; Zhou W; Liu X
    Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
    Zhang X; Gao D; Fang K; Guo Z; Li L
    Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
    Sheikholeslami A; Nabiuni M; Arefian E
    Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway.
    Park S; Han SH; Kim HG; Jeong J; Choi M; Kim HY; Kim MG; Park JK; Han JE; Cho GJ; Kim MO; Ryoo ZY; Choi SK
    Mol Cell Probes; 2019 Oct; 47():101440. PubMed ID: 31445970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.
    Zhang H; Fan Q
    Oncol Rep; 2015 Oct; 34(4):2163-70. PubMed ID: 26239614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
    Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
    Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
    Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
    Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
    Wang Y; Wei Y; Fan X; Zhang P; Wang P; Cheng S; Zhang J
    Thorac Cancer; 2020 Jun; 11(6):1613-1620. PubMed ID: 32291953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
    Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
    Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.